CausalSentinel

Protein Dossier — ITIH1 (Inter-alpha-trypsin inhibitor heavy chain H1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: K43 Ventral hernia 0.00141 0.000444 0.00153 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: K43 Ventral hernia 0.00141 0.000444 0.00153 Inverse variance weighted 2 trans NA
Neo-neuroticism -1.04 0.365 0.00425 Wald ratio 1 trans NA
Subjective well being 0.0283 0.0106 0.00766 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.00347 0.0014 0.0134 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.00347 0.0014 0.0134 Inverse variance weighted 2 trans NA
Forearm bone mineral density -0.102 0.0417 0.0146 Inverse variance weighted 2 trans NA
Forearm bone mineral density -0.102 0.0417 0.0146 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R11 Nausea and vomiting 0.000998 0.000419 0.0173 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R11 Nausea and vomiting 0.000998 0.000419 0.0173 Inverse variance weighted 2 trans NA
Pulse rate -0.0269 0.0115 0.0194 Inverse variance weighted 2 trans NA
Pulse rate -0.0269 0.0115 0.0194 Inverse variance weighted 2 trans NA
…and 170 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

131 association rows across 92 traits (111 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Single Ig IL-1-related receptor levels 3e-1748 rs1042779 1 GCST90249554 no MR -> candidate analysis
Inter-alpha-trypsin inhibitor heavy chain H1 levels 1e-865 rs2286798 1 GCST90247968 no MR -> candidate analysis
Janus kinase and microtubule-interacting protein 3 levels 2e-500 rs1042779 1 GCST90248145 no MR -> candidate analysis
Blood protein levels 3e-321 rs678 13 GCST006585 no MR -> candidate analysis
Single Ig IL-1-related receptor levels (SIGIRR.8326.63.3) 2e-312 rs1042779 1 GCST90242826 no MR -> candidate analysis
Janus kinase and microtubule-interacting protein 3 levels (J 3e-285 rs1042779 1 GCST90241663 no MR -> candidate analysis
Serum levels of protein ITIH1 4e-277 rs2286798 1 GCST90089947 no MR -> candidate analysis
Arylamine N-acetyltransferase 1 levels 6e-240 rs678 1 GCST90246590 no MR -> candidate analysis
Inter-alpha-trypsin inhibitor heavy chain H1 levels (ITIH1.7 2e-171 rs1042779 1 GCST90241535 no MR -> candidate analysis
ITIH1 protein levels 3e-80 rs678 1 GCST90469649 no MR -> candidate analysis
Ubiquitin-conjugating enzyme E2 Q1 level in Chronic kidney d 1e-73 rs1042779 1 GCST90235839 no MR -> candidate analysis
Serum levels of protein C15orf48 9e-48 rs678 1 GCST90089403 no MR -> candidate analysis
…and 80 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 150 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
osteoarthritis, hip 0.709 common-variant locus no MR -> candidate analysis
schizophrenia 0.585 common-variant locus MR: beta=0.0278, p=0.33 (trans)
major depressive disorder 0.571 common-variant locus MR: beta=-0.0579, p=0.483 (trans)
bipolar disorder 0.543 common-variant locus MR: beta=-0.000556, p=0.103 (trans)
osteoarthritis 0.499 common-variant locus MR: beta=-0.0716, p=0.479 (trans)
autism spectrum disorder 0.48 common-variant locus no MR -> candidate analysis
attention deficit-hyperactivity disorder 0.463 common-variant locus no MR -> candidate analysis
total hip arthroplasty 0.446 common-variant locus no MR -> candidate analysis
psychiatric disorder 0.341 common-variant locus no MR -> candidate analysis
eye disorder 0.341 common-variant locus no MR -> candidate analysis
nervous system disorder 0.341 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.303 common-variant locus no MR -> candidate analysis
anxiety disorder 0.285 common-variant locus no MR -> candidate analysis
osteoarthritis, knee 0.283 common-variant locus MR: beta=-0.0716, p=0.479 (trans)
carpal tunnel syndrome 0.282 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=6.8e-29, LOEUF=1.07 — LoF-tolerant
GWAS Catalog 173 unique SNPs / 444 rows
ClinVar 191 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance